Current Medicinal Chemistry

Editorial [Hot Topic: Relevance of Integration at the Membrane Level of Receptor-Receptor Interactions in Neurodegenerative Diseases and Drug Addiction (Guest Editor: Sergio Tanganelli)]
pp. 303-303(1)
Author: Tanganelli, Sergio

Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders
pp. 304-316(13)
Authors: Tanganelli, S.; Antonelli, T.; C. Tomasini, M.; Beggiato, S.; Fuxe, K.; Ferraro, L.

The Importance of the Adenosine A2A Receptor-Dopamine D2 Receptor Interaction in Drug Addiction
pp. 317-355(39)
Authors: Filip, M.; Zaniewska, M.; Frankowska, M.; Wydra, K.; Fuxe, K.

GPCR Heteromers and their Allosteric Receptor-Receptor Interactions
pp. 356-363(8)
Authors: Fuxe, K.; O. Borroto-Escuela, D.; Marcellino, D.; Romero-Fernandez, W.; Frankowska, M.; Guidolin, D.; Filip, M.; Ferraro, L.; Woods, A.S.; Tarakanov, A.; Ciruela, F.; F. Agnati, L.; Tanganelli, S.

DNA Interstrand Cross-Linking Agents and their Chemotherapeutic Potential
pp. 364-385(22)
Authors: Brulikova, L.; Hlavac, J.; Hradil, P.

Nitric Oxide: State of the Art in Drug Design
pp. 386-405(20)
Authors: Serafim, R.A.M.; Primi, M.C.; Trossini, G.H.G.; Ferreira, E.I.

New Perspectives in Antiplatelet Therapy
pp. 406-427(22)
Authors: Tello-Montoliu, A.; Jover, E.; Rivera, J.; Valdes, M.; Angiolillo, D.J.; Marin, F.

Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System
pp. 428-437(10)
Authors: Catena-Dell'Osso, Mario; Marazziti, Donatella; Rotella, Francesco; Bellantuono, Cesario

Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity
pp. 438-453(16)
Authors: Robak, E.; Robak, T.

Transforming Growth Factor β Signaling Perturbation in the Loeys-Dietz Syndrome
pp. 454-460(7)
Authors: Pezzini, A.; Del Zotto, E.; Giossi, A.; Volonghi, I.; Costa, P.; Padovani, A.